Your browser doesn't support javascript.
loading
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Riedel, Richard F; Ballman, Karla V; Lu, Yao; Attia, Steven; Loggers, Elizabeth T; Ganjoo, Kristen N; Livingston, Michael B; Chow, Warren; Wright, Jennifer; Ward, John H; Rushing, Daniel; Okuno, Scott H; Reed, Damon R; Liebner, David A; Keedy, Vicki L; Mascarenhas, Leo; Davis, Lara E; Ryan, Christopher; Reinke, Denise K; Maki, Robert G.
Afiliación
  • Riedel RF; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Ballman KV; Weill Cornell Medicine, New York, New York, USA.
  • Lu Y; Weill Cornell Medicine, New York, New York, USA.
  • Attia S; Mayo Clinic, Jacksonville, Florida, USA.
  • Loggers ET; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Ganjoo KN; Stanford Cancer Institute, Stanford University, Stanford, California, USA.
  • Livingston MB; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
  • Chow W; City of Hope Cancer Center, Duarte, California, USA.
  • Wright J; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Ward JH; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Rushing D; Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA.
  • Okuno SH; Mayo Clinic, Rochester, Minnesota, USA.
  • Reed DR; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Liebner DA; The Ohio State University, Columbus, Ohio, USA.
  • Keedy VL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Mascarenhas L; Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Davis LE; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Ryan C; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Reinke DK; Sarcoma Alliance for Research through Collaboration (SARC), Ann Arbor, Michigan, USA.
  • Maki RG; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Oncologist ; 25(11): e1655-e1662, 2020 11.
Article en En | MEDLINE | ID: mdl-32701199
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Liposarcoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Piridinas / Liposarcoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos